Abstracts Archive - Page 300 of 1683 - ATC Abstracts

2021 American Transplant Congress
Evaluating Pneumocystis Jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients
J. Sharkey, K. McMurry, J. Park, C. Carlson, K. Gregg, D. Kaul, D. Lyu, L. Fitzgerald
Michigan Medicine, Ann Arbor, MI
*Purpose: The incidence of Pneumocystis jiroveci pneumonia (PJP) in lung transplant recipients (LTRs) on PJP prophylaxis is not well documented yet reported as high as…
2021 American Transplant Congress
Epidemiology and Risk Factors for Invasive Fungal Infection in Pancreas Transplant in the Absence of Fungal Prophylaxis
J. Burkey¹, J. M. Chen², A. A. Sharfuddin², M. S. Yaqub², A. J. Lutz², J. A. Powelson², J. A. Fridell², N. Barros²
¹Butler University College of Pharmacy and Health Sciences, Indianapolis, IN, ²Indiana University Health, Indianapolis, IN
*Purpose: Invasive fungal infections (IFI) remain a rare yet dreaded complication following pancreas transplantation. Current guidelines recommend antifungal prophylaxis in patients with 1 or more…
2021 American Transplant Congress
Molecular Epidemiology of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Bloodstream Infections Among Solid Organ Transplant Recipients
J. A. Anesi¹, E. Lautenbach¹, P. D. Tamma², K. A. Thom³, K. Alby⁴, E. A. Blumberg¹, W. Bilker¹, J. Omorogbe¹, P. Tolomeo¹, A. Werzen³, J. Han⁵
¹University of Pennsylvania, Philadelphia, PA, ²Johns Hopkins University, Baltimore, MD, ³University of Maryland, Baltimore, MD, ⁴University of North Carolina, Chapel Hill, NC, ⁵GlaxoSmithKline, Rockville, MD
*Purpose: Solid organ transplant recipients (SOTR) have been significantly impacted by the emergence of multidrug-resistant bacteria, including extended-spectrum cephalosporin-resistant (ESC-R) Enterobacterales (EB). We determined the…
2021 American Transplant Congress
Impact of a Pharmacist-driven Immunization Clinic on Vaccination Rates in Pre-liver Transplant Patients
A. Poparad-Stezar¹, B. Summers¹, M. Fitzmaurice¹, K. Hakamiun², N. Sulejmani³, A. Jantz¹
¹Henry Ford Hospital, Detroit, MI, ²Select Medical, Wyandotte, MI, ³CareDx, Inc., Sterling Heights, MI
*Purpose: Infectious diseases are a leading cause of morbidity and mortality among patients with end-stage liver disease (ESLD). Vaccination data of ESLD patients pre- and…
2021 American Transplant Congress
The Effect of the Different Donor-Derived HLA T-Cell Epitope Targets on the Development of T Cell-Mediated Rejection After Kidney Transplantation
A. Senev, E. Van Loon, M. Emonds, M. Naesens
Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
*Purpose: Many kidney allografts fail due to rejections caused by the donor and recipient HLA incompatibility. Recent studies have shown that HLA-DR and DQ mismatches…
2021 American Transplant Congress
Impact of a Cmv Cell Mediated Immunity Based Protocol on Guiding Cmv Prophylaxis Following Pediatric Liver Transplantation – A Single Center Experience
G. Kalkan¹, S. Ball², L. McConnell², D. M. Desai³, A. Aqul³, P. K. Sue¹
¹Infectious Disease, University of Texas Southwestern Medical Center, Dallas, TX, ²Solid Organ Transplant Program, Children's Health, Dallas, TX, ³Solid Organ Transplant Program, University of Texas Southwestern Medical Center, Dallas, TX
*Purpose: Cytomegalovirus (CMV) is an important cause of morbidity following pediatric orthotopic liver transplantation (OLT), especially among high risk (HR) CMV D+/R- recipients. In 2019,…
2021 American Transplant Congress
Effective Patient Throughput on the Transplant Surgery Service
E. M. Thomas¹, P. K. Shah¹, S. Beasley², A. Saad¹, M. Rani¹, F. Cigarroa¹
¹UT Health San Antonio, San Antonio, TX, ²University Health, San Antonio, TX
*Purpose: Hospital bed capacity and patient throughput are persistent challenges for medical centers. One established strategy for increasing patient throughput and decompressing Emergency Departments is…
2021 American Transplant Congress
Use of Granulocyte Colony Stimulating Factor After Lung Transplantation is Not Associated with Increased Likelihood of Acute Cellular Rejection
S. Fredrick¹, C. Iasella², L. Sacha³, R. Rivosecchi³, M. Morrell³, P. Sanchez³, J. Pilewski³, M. Snyder³, J. McDyer³, C. Moore³
¹University of Rochester Medical Center, Rochester, NY, ²University of Pittsburgh School of Pharmacy, Pittsburgh, PA, ³University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: The cause of neutropenia in lung transplant recipients is multifactorial, including medications, viral infections, and antecedent disease. Granulocyte colony-stimulating factor (G-CSF) is commonly used…
2021 American Transplant Congress
Development of Diagnosis Method of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach
H. Iwamoto¹, M. Sugimoto², O. Konno¹, I. Akashi³, M. Okihara¹, Y. Kihara¹, T. Ueno¹
¹Kidney Transplantation Surgery, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan, ²Research and Development Center for Minimally Invasive and Preemptive Medicine, Institute of Medi, Tokyo Medical University, Tokyo, Japan, ³Kidney transplantation Surgery, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan
*Purpose: Presently, a definitive diagnosis of organ dysfunction after transplantation (such as acute rejection) is dependent on conventional histopathological evaluation using an invasive biopsy procedure…
2021 American Transplant Congress
Inflammation in Scarred Cortex (i-IFTA) is Significantly Associated with T Cell-mediated Rejection (TCMR), but Not Antibody-mediated Rejection (ABMR), in Renal Allograft Biopsies (Bx)
H. Zhang
Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: I-IFTA in renal allograft Bx has been found to be associated with decreased death-censored graft survival. Moderate to severe i-IFTA (2 or 3) is…